- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Niger Plans to Renegotiate Uranium Terms with Areva: President
Mining Weekly reported that Niger wants to renegotiate its partnership terms on uranium mining with Areva, a deal which generates €100-million for the country. Niger president Mahamadou Issoufou said they are also looking to partner with other mining investors in their effort to boost their country’s economy.
Mining Weekly reported that Niger wants to renegotiate its partnership terms on uranium mining with Areva, a deal which generates €100-million for the country. Niger president Mahamadou Issoufou said they are also looking to partner with other mining investors in their effort to boost their country’s economy.
As quoted in the market news:
This represents just 5% of our budget, it’s not acceptable. That’s why I have asked to re-equilibrate the terms of the deal between Areva and Niger,” he said.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.